ClinicalTrials.Veeva

Menu

Superficial Cervical Plexus Block Versus Ketamine in the Prevention of Chronic Pain After Thyroidectomy (Thyrobloket)

U

University Tunis El Manar

Status and phase

Completed
Phase 4

Conditions

Chronic Pain
Thyroidectomy

Treatments

Procedure: Superficial cervical plexus block
Drug: Ketamine perfusion

Study type

Interventional

Funder types

Other

Identifiers

NCT07230392
Thyrobloket

Details and patient eligibility

About

The goal of our work is to to compare the effect of preemptive Ketamine administration versus superficial cervical plexus block on the incidence of postoperative neuropathic pain in patients undergoing thyroidectomy

Enrollment

69 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 18 to 80 years
  • Scheduled for thyroidectomy under general anesthesia.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Able to understand the study procedures and provide written informed consent

Exclusion criteria

  • Known allergy to ketamine or local anesthetics
  • Severe renal impairment with estimated Glomerular Filtration Rate (eGFR) under 30 mL/min
  • History of neurological disorders
  • History of psychiatric illness
  • History of severe cardiac disease (NYHA III-IV) or serious arrhythmias
  • Pregnancy or breastfeeding
  • Morbid obesity (BMI > 40 kg/m²)
  • Cognitive or communication impairment
  • Refusal to participate

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

69 participants in 2 patient groups

BCS Group
Active Comparator group
Description:
Patients received a bilateral ultrasound-guided superficial cervical plexus block after induction (Ropivacaine 0.2%,with a volume of 10 mL administered to each side)
Treatment:
Procedure: Superficial cervical plexus block
KETA group
Active Comparator group
Description:
Patients received intravenous ketamine (0.25 mg/kg bolus followed by a 2 µg/kg/min infusion).
Treatment:
Drug: Ketamine perfusion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems